Twitter Beğeni Hilesi

Congrats to #TeamUHN's Erica Tsang on receiving the OncoDaily Yvonne Award in the Challenging the Status Quo category! Dr. Tsang’s research at Princess Margaret Cancer Centre is centered around genomics and clinical trials, with a particular focus on pancreatic cancer.

ASCO President reflects on the journey of transformative improvement seen in multiple tumors types including melanoma, lung, breast & kidney cancer. Nevertheless, she reminds all of us that difficult conversations are central to cancer practice & that integrating palliative care

Honoured to pose with ASCO CEO at the end of the opening plenary and with the 🍁 crowd from Princess Margaret Cancer Centre and friends

Excited to see news about ASCO Breakthrough in Chicago at #ASCO24! Come to Yokohama, Japan for one of the brightest moments in oncology this year! Register to join us now! Team photo with past Chair Karnosky award winner Lillian Siu @asco #ASCOBT24  breakthrough.asco.org

Arguably the best #highlight of #ASCO24 is the Princess Margaret Cancer Centre 🇨🇦#DrugDevelopmentProgram #alumni get-together! Congrats and thankful to Lillian Siu for years of exceptional #mentorship grooming #leaders of #oncology worldwide 🌎😊 Ben Tran ChenLee Tom Wei-Wu Chen Natalie Cook 💙

Fantastic Wharton Day speaker Prof Lisa Licitra from Instituto Nazionale dei Tumori Milan on how we can collectively learn from transcriptomic data in HNSCC Princess Margaret Cancer Centre

The Canadian Cancer Trials Group (#CCTG) is joining forces with Marathon of Hope Cancer Centres Network (#MOHCCN) to conduct three pan-Canadian projects with the goal of increasing the effectiveness of #immunotherapy for cancer patients. #CancerResearch #ClinicalTrials bit.ly/4cvVlPb

#ENASymp24 Deadline Alert: 1 week left to submit your abstract. Will you be joining us in Barcelona? eortc.org/ena EORTC National Cancer Institute AACR

#ASCOBT24 Abstract titles are now released! conferences.asco.org/breakthrough/a… Check out the high quality Trials, Translational Science on #Omics #Newdrugs #HealthTech #AI that will be presented at this year’s meeting! Register now to join us in Yokohama in Aug! ASCO Lillian Siu

In the latest episode of Believe in Progress, we speak with Dr. William Pao and Dr. Lillian L. Siu about efforts to foster greater diversity in cancer research and leadership. bit.ly/3XXpkvc

My take on #ASCOBT24 and why this is a meeting not to be missed and will only grow from strength to strength! Lillian Siu Robin Zon, MD, FACP, FASCO ASCO ASCO Breakthrough Will Explore Artificial Intelligence, Novel Therapeutics, and Health Equity dailynews.ascopubs.org/do/asco-breakt…

We congratulate our CEO, Margaret Foti, PhD, MD (hc), on being honored by the Philadelphia Business Journal as a member of their 2024 class of Women of Influence. Margaret Foti, PhD, MD (hc)

AACR members: The #AACR25 program committee invites you to submit a novel, interdisciplinary topic to be considered for inclusion in the program of the AACR Annual Meeting 2025. Submission Deadline: Tuesday, August 6. Learn more: bit.ly/3WNArpD

Tune into the Believe in Progress podcast as we discuss AACR Project GENIE with Dr. Shawn Sweeney and Dr. Philippe Bedard. Listen to how this initiative is revolutionizing precision medicine in oncology tomorrow. bit.ly/3Ad61UN

#ASCOBT24 #PrecisionOncology is always an important topic embedded in Cancer Care and #innovation today. Insightful kickoff by Daniel Tan taking a global lens to state of play in precision oncology and barriers. Love the Swiss chess concept! 🧀 ASCO Robin Zon, MD, FACP, FASCO

Wonderful first day #ASCOBT24! Compelling sessions on a range of topics: AI, current and future state of precision oncology, and new research on trials & developmental therapeutics. It's also been a joy connecting with our global oncology community. Together we shine brighter!

Congratulations to Margaret Foti, PhD, MD (hc) Margaret Foti, PhD, MD (hc), who will receive the 2024 Beacon Award for Women Leaders in Oncology from AIM-HI Accelerator Fund and National Foundation for Cancer Research. Learn more: bit.ly/4fwU5O5

Program Chair Melvin LK CHUA opening Day 3 of #ASCOBT24, with keynote Dr Shimon Sakaguchi dissecting Treg biology as a strategy of tumor immunity ASCO

#ASCOBT24 Final but equally important session on #RWE #realworldevidence and #precisiononcology #clinicaltrials Shaalan Beg MD MBA FASCO Lillian Siu Dr Hidetoshi_Hayashi Dr Janet_Dancey

Out now our review on #BispecificAntibodies Trends in Cancer!👉t.ly/L0BS0 We cover preclinical & clinical developments, trials data & challenges ahead A joy working w the dream team! Mercedes Herrera Giulia Pretelli Thiago M Steiner Lillian Siu Elena Garralda Jayesh Desai